June 17, 2021
Part 2: Switching from Warfarin to a NOAC
An interactive discussion on the latest recommendations for practical management of anticoagulation in patients with NVAF ( non-valvular atrial fibrillation)
Speaker: Lynne Garforth
This promotional content has been organised and funded by Bristol Myers Squibb on behalf of the BMS/Pfizer Alliance. This is intended for UK Healthcare Professionals only. Treatment options will be discussed at this meeting. For Eliquis® (apixaban) prescribing information and adverse event reporting, please click here.
Sign up for this Event using the form below:
Please note that all fields marked with an asterisk (*) are mandatory.